99 related articles for article (PubMed ID: 6828317)
21. Natural killer cell activities of patients with breast cancer against different target cells.
Hamilton G; Reiner A; Teleky B; Roth E; Kolb R; Spona J; Jakesz R
J Cancer Res Clin Oncol; 1988; 114(2):191-6. PubMed ID: 3350852
[TBL] [Abstract][Full Text] [Related]
22. The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer.
Brenner BG; Margolese RG
Cancer; 1991 Aug; 68(3):482-8. PubMed ID: 2065267
[TBL] [Abstract][Full Text] [Related]
23. Role of natural killer cells in cancer.
Pross HF; Lotzová E
Nat Immun; 1993; 12(4-5):279-92. PubMed ID: 8257832
[TBL] [Abstract][Full Text] [Related]
24. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status.
Zhang R; Xu J; Hong K; Yuan L; Peng H; Tang H; Ma P; Zhang Y; Xing H; Ruan Y; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S9-17. PubMed ID: 18172398
[TBL] [Abstract][Full Text] [Related]
25. [Natural killer activity and sensitization of the lymphocytes to tissue antigens in lung cancer].
Red'ko AA; Malygin AM; Dvaladze NA; Pleskach VA; Kutushev FKh
Vestn Khir Im I I Grek; 1988 Feb; 140(2):12-5. PubMed ID: 3388698
[TBL] [Abstract][Full Text] [Related]
26. Natural killer (NK) cell activity of women with gross cystic disease is inhibited in vitro by breast cyst fluid.
Ardizzoja M; Masera RG; Tacconis P; Sartori ML; Arisio R; Massobrio M; Angeli A
Anticancer Res; 1994; 14(2A):555-9. PubMed ID: 8017860
[TBL] [Abstract][Full Text] [Related]
27. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
Guo KY; Mei JZ; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
[TBL] [Abstract][Full Text] [Related]
28. Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E.
Srivastava R; Aggarwal R; Bhagat MR; Chowdhury A; Naik S
J Viral Hepat; 2008 Dec; 15(12):910-6. PubMed ID: 18673427
[TBL] [Abstract][Full Text] [Related]
29. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
30. Stress-related hormonal suppression of natural killer activity does not show menstrual cycle variations: implications for timing of surgery for breast cancer.
Garland M; Doherty D; Golden-Mason L; Fitzpatrick P; Walsh N; O'Farrelly C
Anticancer Res; 2003; 23(3B):2531-5. PubMed ID: 12894537
[TBL] [Abstract][Full Text] [Related]
31. Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer.
Visonneau S; Cesano A; Porter DL; Luger SL; Schuchter L; Kamoun M; Torosian MH; Duffy K; Sickles C; Stadtmauer EA; Santoli D
Clin Cancer Res; 2000 May; 6(5):1744-54. PubMed ID: 10815893
[TBL] [Abstract][Full Text] [Related]
32. Natural killer cell numbers and cytotoxic activity in pediatric Hodgkin disease.
Ikincioğullari A; Doğu F; Babacan E; Oflaz G; Ertem U; Yavuz G; Unal E; Gözdaşoğlu S; Taçyildiz N; Dağdemir A; Cavdar AO
Pediatr Hematol Oncol; 2000 Mar; 17(2):133-9. PubMed ID: 10734655
[TBL] [Abstract][Full Text] [Related]
33. The participation of natural cytotoxicity in the control of malignant disease.
Draca SR
Panminerva Med; 1993 Sep; 35(3):123-6. PubMed ID: 8090524
[TBL] [Abstract][Full Text] [Related]
34. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women.
Cunningham-Rundles S; Filippa DA; Braun DW; Antonelli P; Ashikari H
J Natl Cancer Inst; 1981 Sep; 67(3):585-90. PubMed ID: 6944530
[TBL] [Abstract][Full Text] [Related]
35. Natural killer cell activity and distant metastasis in rectal cancers treated surgically with and without neoadjuvant chemoradiotherapy.
Koda K; Saito N; Oda K; Seike K; Kondo E; Ishizuka M; Takiguchi N; Miyazaki M
J Am Coll Surg; 2003 Aug; 197(2):254-60. PubMed ID: 12892809
[TBL] [Abstract][Full Text] [Related]
36. [K-cell activity in bone cancer patients].
Csató Z; Garam T; Németh-Csóka A; Köllö K; Tótpál K; Bartalits L
Orv Hetil; 1983 Oct; 124(40):2423-5. PubMed ID: 6672709
[No Abstract] [Full Text] [Related]
37. Human breast cancer and impaired NK cell function.
Garner WL; Minton JP; James AG; Hoffmann CC
J Surg Oncol; 1983 Sep; 24(1):64-6. PubMed ID: 6887939
[TBL] [Abstract][Full Text] [Related]
38. Natural killer activity in patients with breast cancer.
Bonilla F; Alvarez-Mon M; Merino F; Girón JA; Menéndez JL; Espana P; Durántez A
Eur J Gynaecol Oncol; 1990; 11(2):103-9. PubMed ID: 2379508
[TBL] [Abstract][Full Text] [Related]
39. A review of the effects of hypnosis on the immune system in breast cancer patients: a brief communication.
Hudacek KD
Int J Clin Exp Hypn; 2007 Oct; 55(4):411-25. PubMed ID: 17786658
[TBL] [Abstract][Full Text] [Related]
40. Natural killer activity in thyroid cancer patients.
Boros P; Balázs G; Szegedi G
Haematologia (Budap); 1987; 20(3):189-93. PubMed ID: 3692337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
